Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages
Antonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, Yeşim Beşli, Pierre Bogaerts, Rafael Cantón, Cansu Cimen, Peter D Croughs, Olivier Denis, Mateja Pirš
Pregledni znanstveni članek
Oznake: Pseudomonas aeruginosa;antimicrobial susceptibility;profiles;resistance mechanisms;clonal lineages;
Scope: Pseudomonas aeruginosa, a ubiquitous opportunistic pathogen considered one of the paradigms of antimicrobial resistance, is among the main causes of hospital-acquired and chronic infections associated with significant morbidity and mortality. This growing threat results from the extraordinary ...
Leto: 2024 Vir: Medicinska fakulteta (UL MF)
CVOT summit report 2025
Oliver Schnell, Oliver Schnell, Arnav Agarwal, Michel Azizi, Dennis Ballwieser, Katharine Barnard-Kelly, Matthias Blüher, Elisabetta Bugianesi, Ana Cebrian, Antonio Ceriello, Pratik Choudhary, Tadej Battelino
Pregledni znanstveni članek
Oznake: diabetes;CGM;soluble guanylate cyclase stimulators;obesity;aldosterone synthase inhibitors;
The 11th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 20–21, 2025. The Summit provided a multidisciplinary forum to review and discuss recent outcome trials investigating emerging pharmacological therapies targe ...
Leto: 2026 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
CVOT Summit Report 2023
Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Alice Cheng, Beatriz Fernandez-Fernandez, Thomas Forst, Juan-Pablo Frias, James R. Gavin
Kratki znanstveni prispevek
Oznake: sladkorna bolezen;srčnožilne bolezni;srčni zastoj;kronična ledvična bolezen;
Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recently completed outcomes trials including dapagliflozin (DAPA-MI), semaglutide (SELECT and STEP-HFpE ...
Leto: 2024 Vir: Medicinska fakulteta (UL MF)
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: